Newsletter
16.11.2022
PMA Insights: Week 46 SPECIAL EDITION ISPOR 2022 R...

We summarise the ISPOR Europe 2022 conference including plenary sessions on HTA, patient-centered re...

Read more
Insider Insights
04.11.2022
UK: NICE conditionally recommends digital cognitiv...

NICE guidance published today on digital health technologies suggest they can be used to help young ...

Read more
News
02.11.2022
PMA Insights: Week 44

We summarise four handpicked articles from pharmaceutical, pricing and market access that are worth ...

Read more
Insider Insights
01.11.2022
Germany – Is digitisation the gateway to better ...

Digitisation is thought to contribute significant improvements in knowledge generation in drug devel...

Read more
Newsletter
06.10.2022
PMA Insights: Week 40

We summarise four handpicked articles from pharmaceutical, pricing and market access that are worth ...

Read more
Insider Insights
06.10.2022
DEKRA becomes the first new body for certifying me...

The Medicines and Healthcare products Regulatory Agency (MHRA) has appointed DEKRA as the first new ...

Read more
Insider Insights
06.10.2022
France: An update on the transitional reimbursemen...

The aim of the transitional reimbursement mechanism (PECT) launched in February 2021, was to allow r...

Read more
Articles
24.08.2022
Healthcare apps and devices in the UK: Who picks u...

Digital therapeutics: a growing market The year is 2008 and Apple have just added a new category to ...

Read more
Articles
24.08.2022
What does it take to secure access to digital heal...

Introduction Digital health applications (apps) are designed to improve personalised care and popula...

Read more
Articles
24.08.2022
AI could transform diabetes management to improve ...

Introduction Around the world, it is estimated that 422 million people have diabetes, that’s almos...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.